KRO(KRO)
KRO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.06B | $2.10B | $2.19B |
| Low | $2.04B | $2.08B | $2.17B |
| High | $2.09B | $2.12B | $2.22B |
| EBITDA Avg | $161M | $193M | $194M |
| Low | $160M | $191M | $193M |
| High | $162M | $194M | $195M |
| EBIT Avg | $99M | $132M | $134M |
| Low | $98M | $130M | $133M |
| High | $100M | $133M | $135M |
| Net Income Avg | $46M | $71M | $72M |
| Low | $45M | $70M | $71M |
| High | $47M | $72M | $73M |
| EPS Avg | $0.40 | $0.61 | $0.63 |
| Low | $0.39 | $0.61 | $0.62 |
| High | $0.41 | $0.62 | $0.64 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $537M | $460M | $513M | $577M |
| Low | $528M | $452M | $503M | $566M |
| High | $547M | $468M | $522M | $587M |
| EBITDA Avg | $60M | $48M | $53M | $56M |
| Low | $59M | $48M | $53M | $56M |
| High | $60M | $48M | $54M | $57M |
| EBIT Avg | $43M | $32M | $37M | $40M |
| Low | $43M | $31M | $37M | $40M |
| High | $44M | $32M | $38M | $41M |
| Net Income Avg | $22M | $13M | $17M | $20M |
| Low | $21M | $13M | $17M | $19M |
| High | $22M | $14M | $18M | $20M |
| EPS Avg | $0.19 | $0.12 | $0.15 | $0.17 |
| Low | $0.19 | $0.11 | $0.15 | $0.17 |
| High | $0.19 | $0.12 | $0.15 | $0.17 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |